Manifestaciones Gastrointestinales de COVID-19: puesta al día y revisión de literatura / Gastrointestinal Manifestations of COVID-19: update and literature review
Rev. méd. Maule
; 37(1): 93-104, jun. 2022.
Article
em Es
| LILACS
| ID: biblio-1397752
Biblioteca responsável:
CL1.1
ABSTRACT
The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA virus belonging to the beta coronavirus family, it is the cause of the COVID-19 disease and the pandemic that has revolutionized and challenged the medical research profession and health systems around the world. With the first coronavirus SARS-CoV, the important role of the angiotensin 2-converting enzyme (ACE2) in the pathophysiology of the disease caused by the virus was discovered, a discovery that would lay the foundations on which research on the new coronavirus is based. The virus is capable of producing disease with a wide spectrum of clinical presentation, from asymptomatic patients to patients with severe acute respiratory distress syndrome (ARDS) requiring admission to intensive care units (ICU). The most commonly described symptoms are fever, cough, myalgia, and dyspnea. However, and with advances in the knowledge of SARS-CoV-2 infection, it has been discovered that gastrointestinal (GI) symptoms are frequent and have been associated with severe disease. Viral RNA has been found in feces, urine, blood, and other fluids, which could mean that there are other routes of infection that have not been considered a threat by the medical community until now. In this article, an updated bibliographic review of this topic is presented, with articles selected from the PubMed platform.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
LILACS
Assunto principal:
Pancreatite
/
Pandemias
/
COVID-19
Tipo de estudo:
Etiology_studies
Limite:
Humans
Idioma:
Es
Revista:
Rev. méd. Maule
Assunto da revista:
MEDICINA
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Chile
País de publicação:
Chile